Skye Bioscience, Inc. - SKYE

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$12.14M
QoQ value delta ($000)
-$68.23M (-84.89%)
Implied price effect (QoQ)
-80.94%
Shares
Total shares
16,217,590
QoQ shares delta
-4,236,890 (-20.71%)
Total shares held by funds (by quarter)

Market chart (SKYE)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
5AM Venture Management, LLC 7,258 9,681,763 2.28%
Versant Venture Management, LLC 1,505 2,007,704 1.0%
BAKER BROS. ADVISORS LP 1,087 1,450,638 0.01%
VANGUARD GROUP INC 662 882,785 0.0%
SPHERA FUNDS MANAGEMENT LTD. 359 478,928 0.07%
MILLENNIUM MANAGEMENT LLC 285 380,478 0.0%
BlackRock, Inc. 211 281,841 0.0%
PLATINUM INVESTMENT MANAGEMENT LTD 174 233,095 0.04%
GEODE CAPITAL MANAGEMENT, LLC 157 210,151 0.0%
Schonfeld Strategic Advisors LLC 70 93,407 0.0%
CITADEL ADVISORS LLC 62 82,700 0.0%
STATE STREET CORP 56 75,326 0.0%
XTX Topco Ltd 39 53,040 0.0%
TWO SIGMA INVESTMENTS, LP 38 51,706 0.0%
TWO SIGMA ADVISERS, LP 30 40,982 0.0%
HRT FINANCIAL LP 20 27,348 0.0%
JANE STREET GROUP, LLC 18 24,615 0.0%
Engineers Gate Manager LP 17 23,138 0.0%
GSA CAPITAL PARTNERS LLP 17 22,877 0.0%
BARCLAYS PLC 15 21,251 0.0%
NORTHERN TRUST CORP 15 20,142 0.0%
GROUP ONE TRADING LLC 13 18,197 0.0%
R Squared Ltd 11 14,782 0.01%
UBS Group AG 9 13,286 0.0%
CAPITAL ADVISORS INC/OK 7 10,000 0.0%